Mimedx (MDXG) Other Accumulated Expenses (2011 - 2026)

Mimedx has disclosed Other Accumulated Expenses across 16 years of filings, most recently posting $4.4 million for Q2 2026.

• In Q2 2026, Other Accumulated Expenses rose 28.7% year-over-year to $4.4 million; the TTM figure through Jun 2026 stood at $4.4 million (up 28.7% YoY), while the FY2025 annual figure was $5.8 million, up 28.47% from the prior year.
• Other Accumulated Expenses came in at $4.4 million for Q2 2026 at Mimedx, down from $6.1 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $6.1 million in Q1 2026 to a low of $1.6 million in Q1 2022.
• Average Other Accumulated Expenses over 5 years is $3.2 million, with a median of $2.7 million recorded in 2023.
• Year-over-year, Other Accumulated Expenses dropped 6.04% in 2022 and surged 126.92% in 2024.
• Over 5 years, Other Accumulated Expenses stood at $1.8 million in 2022, then jumped by 57.8% to $2.9 million in 2023, then surged by 55.74% to $4.5 million in 2024, then grew by 28.47% to $5.8 million in 2025, then fell by 24.18% to $4.4 million in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $4.4 million in Q2 2026, $6.1 million in Q1 2026, and $5.8 million in Q4 2025.